Trial Information
Diphenoxylate / Atropine to Decrease Bowel Activity During F-18 FDG PET
Inclusion Criteria
Inclusion Criteria
- Males and females 18 years of age or older
- Subjects pre-scheduled for clinically-indicated PET scan
- Subjects with newly diagnosed or recurrent untreated disease (lymphoma) based on
abdominal and/or pelvic adenopathy or masses on CT within 6 months of PET scan
Exclusion Criteria
- Allergy to Lomotil (Diphenoxylate hydrochloride, Atropine sulfate)
- Subjects with one or more episodes of diarrhea within 24 hours prior to PET scan
- Women who are breast-feeding
- Subjects with a history of severe liver disease, jaundice, dehydration, or
narrow-angle glaucoma
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Diagnostic
Outcome Measure:
Reduction of bowel activity
Outcome Time Frame:
1hour
Safety Issue:
No
Authority:
United States: Mayo Clinic
Study ID:
2051-02
NCT ID:
NCT00583323
Start Date:
February 2003
Completion Date:
September 2005
Related Keywords: